Abstract:Objective To investigate the role of phosphoribosyl pyrophosphate synthetase 2 (PRPS2) in lung cancer cell proliferation, tumor growth in vitro, and tumorigenic ability in vivo.Methods Lung cancer A549 cells cultured in vitro were divided into 3 groups: the control group (scramble control shRNA lentivirus infecting cells for 12 h), Lenti-sh1 group (lentivirus Lenti-sh1 infecting cells for 12 h) and Lenti-sh2 group (lentivirus Lenti-sh2 infecting cells for 12 h).These results indicated that the mRNA and protein expression levels of PRPS2 were effectively reduced in the control group as compared with that of the other two groups (both P<0.05).These results indicated that the expression levels of PRPS2 were reduced by PRPS2 shRNA lentivirus in A549 lung cancer cells.Colony formation assay was used to detect the clone number of three groups.The cell proliferation rate was evaluated by a CCK8 assay and cell cycle was detected by flow cytometry.RT-PCR and Western blotting were used to detect the mRNA and protein expression levels of APC, β-catenin, Gsk3β in A549 cells of WNT signaling pathway.Tumors were generated by subcutaneously injecting lung cancer A549 cells from the control, Lenti-sh1 and Lenti-sh2 groups into the right forelimb axillaries of Balb/c nude mice (each group contained 6 mice).The mice were sacrificed at the 6th week to evaluate the weight and volume of tumors.Results Compared with the control group, the number of cell colonies in the Lenti-sh1and Lenti-sh2 groups were reduced (P<0.05).The absorbance value of the Lenti-sh1and Lenti-sh2 groups at 72 and 96h was lower than that of the control group (P<0.05).A significantly higher percentage of cells accumulated in the G0/G1 phase of the cell cycle in the Lenti-sh1and Lenti-sh2 groups as compared with that of the control group.However, the percentage of cells in the S and G2/M phase was lower than that of the control group (all P<0.05).The mRNA and protein levels of APC and β-catenin in the Lenti-sh1and Lenti-sh2 groups were lower than that of the control group but the mRNA and protein levels of Gsk-3β were higher than that of the control group (all P<0.05).The tumor weight and volumes of the the Lenti-sh1and Lenti-sh2 groups decreased significantly as compared with those of the control group (both P<0.05).Conclusion Silencing PRPS2 gene may suppress lung cancer growth, proliferation in vitro, and tumorigenic ability in vivo by regulating the WNT signaling pathway.

Tpd52l2 Silencing Inhibits Lung Cancer Cell Proliferation By Cell Cycle G2/M Phase Arrest

Lentivirus-mediated Knockdown of CTDP1 Inhibits Lung Cancer Cell Growth in Vitro.

TPD52L2 as a potential prognostic and immunotherapy biomarker in clear cell renal cell carcinoma

CDK12 loss inhibits cell proliferation by regulating TBK1 in non-small cell lung cancer cells

Lentivirus-Mediated Knockdown of Tsp50 Suppresses the Growth of Non-Small Cell Lung Cancer Cells Via G0/G1 Phase Arrest

Overexpression of TSPAN8 Promotes Tumor Cell Viability and Proliferation in Nonsmall Cell Lung Cancer.

Knockdown Of Protein Phosphatase 4 Regulatory Subunit 1 Inhibits Growth Of Lung Cancer Cells In Vitro

ANGPTL2/LILRB2 Signaling Promotes the Propagation of Lung Cancer Cells

DNASE 2 B silencing suppresses proliferation and induces cell cycle arrest in non-small cell lung cancer cells

Effects of PRPS2 on lung cancer cell proliferation, tumor growth in vitro, and tumorigenic ability in vivo

PARK2 Suppresses Proliferation and Tumorigenicity in Non-small Cell Lung Cancer.

Overexpression of TPD52L2 in HNSCC: prognostic significance and correlation with immune infiltrates

PDS5B inhibits cell proliferation, migration, and invasion via upregulation of LATS1 in lung cancer cells

MicroRNA-508-3p Regulates the Proliferation of Human Lung Cancer Cells by Targeting G1 to S Phase Transition 1 (GSPT1) Protein.

Tumor protein D52 is upregulated in oral squamous carcinoma cells under hypoxia in a hypoxia-inducible-factor-independent manner and is involved in cell death resistance

Overexpression of 15-Hydroxyprostaglandin Dehydrogenase Inhibits A549 Lung Adenocarcinoma Cell Growth Via Inducing Cell Cycle Arrest and Inhibiting Epithelial-Mesenchymal Transition

USP52 inhibits cell proliferation by stabilizing PTEN protein in non-small cell lung cancer

Selective Up-Regulation of Cdk2 is Critical for Tlr9 Signaling Stimulated Proliferation of Human Lung Cancer Cell

Knockdown of GTF2E2 Inhibits the Growth and Progression of Lung Adenocarcinoma Via RPS4X in Vitro and in Vivo

The Tumor Suppressor TPD52‐Governed Endoplasmic Reticulum Stress is Modulated by APCCdc20

Lats2, a Putative Tumor Suppressor, Inhibits G1/S Transition